GLUE Monte Rosa Therapeutics, Inc.

NEUTRAL Impact: 3/10 Insider Cluster (2 insiders)
Horizon days Filed Jun 1, 2026 Processed 11d 13h ago
Insider cluster: 2 insiders, $163K total
Latest settled — T+1d ⚠ clustered
GLUE ▼ -0.85% at T+1d
NEUTRAL call ✗ call lost -0.85% · α vs SPY -0.15% · entry $17.74 → $17.59
Next anchor: T+5d due 5d ago
Currently $18.24 · +2.79% from $17.74 entry
Entry anchored
Jun 1, 03:59 PM ET
via Databento tick
T+1d
-0.85%
call -0.85% · α -0.15%
$17.59
settled 11d ago
T+5d
call — · α —
due 5d ago
T+20d
call — · α —
in 17d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders at Monte Rosa Therapeutics sold a combined $163K in open-market sales within a week, with the CSO exercising and immediately selling options. The dollar value is trivial relative to the $1.7B market cap (0.01%), making this a routine liquidity event rather than a bearish signal. The cluster is amplified by cross-filing context (earnings, offering, and press events nearby), but the absolute size does not warrant a directional call.

Key Financial Metrics

Direction
selling
Total Value
$163.0K
Insiders
2

Actionable Insight

This cluster is noise. The dollar amounts are immaterial and the sales are tied to option exercises. Monitor for any material corporate events (earnings, pipeline data, financing) that could explain the timing, but no tradeable signal here.

Key Facts

  • CSO Sharon Townson sold 6,000 shares at $19.87 for $119K on 2026-05-29, simultaneously exercising options at $6.14 and $0.
  • COO Jennifer Champoux sold 2,175 shares at $20.00 for $43.5K on 2026-05-27, exercising options at $3.98 and $0.
  • Total open-market sales of $163K represent just 0.01% of Monte Rosa's $1.7B market cap.
  • Both sales were paired with option exercises, indicating tax- or liquidity-driven selling, not a bearish view.
  • Recent insider activity (30d) shows 4 prior sales totaling $384K, consistent with routine portfolio management.

Financial Impact

$163K in open-market sales, 0.01% of market cap

insider ownership

Risk Factors

  • Insider sales could accelerate if the stock continues to rise, but current levels are routine.
  • No fundamental risk signaled by this cluster alone.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GLUE-1780344429152
10 reports for GLUE
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +13.72%Mar 17, 2026
Filters
Rows
Reports for GLUE — sortable, filterable
Type Now
Jun 2, 2026
10d ago
Insider Cluster
NEUTRAL ★ 3/10
$17.59 $17.36▼ −1.31%▼ −1.71%$18.24 (+3.67%)
Jun 2, 2026
10d ago
Press Release
NEUTRAL ★ 2/10
$17.59 $17.36▼ −1.31%▼ −1.71%$18.24 (+3.67%)
Jun 1, 2026
11d ago
Insider Cluster
NEUTRAL ★ 3/10
$17.74 $17.59▼ −0.85%▼ −0.15%$18.24 (+2.79%)
May 7, 2026
5w ago
8-K
MIXED ★ 5/10
$19.81 $19.39▼ −2.12%▼ −2.95%$18.24 (−7.95%)
Apr 20, 2026
7w ago
Press Release
BULLISH ★ 7/10
$19.81 $20.89▲ +5.45%▲ +6.11%$18.24 (−7.95%)
Apr 9, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.05 $17.48▼ −3.16%▼ −3.10%$18.24 (+1.02%)
Mar 17, 2026
12w ago
Press Release
BULLISH ★ 8/10
$16.03 $15.76▼ −1.68%▼ −0.29%$18.24 (+13.76%)
Mar 16, 2026
12w ago
Press Release
MIXED ★ 6/10
$16.35 $16.03▼ −1.96%▼ −2.23%$18.24 (+11.53%)
Mar 2, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.50 $17.96▼ −2.92%▼ −2.00%$18.24 (−1.43%)
Feb 28, 2026
14w ago
Institutional Cluster
BULLISH ★ 6/10
$18.50 $17.96▼ −2.92%▼ −2.00%$18.24 (−1.43%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (52h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access